West Nile virus (WNV), a mosquito-borne single-stranded RNA flavivirus, can cause significant human morbidity and mortality. Our data show that interleukin-10 (IL-10) is dramatically elevated both in vitro and in vivo following WNV infection. Consistent with an etiologic role of IL-10 in WNV pathogenesis, we find that WNV infection is markedly diminished in IL-10 deficient (IL-10-/-) mice, and pharmacologic blockade of IL-10 signaling by IL-10 neutralizing antibody increases survival of WNV-infected mice. Increased production of antiviral cytokines in IL-10-/- mice is associated with more efficient control of WNV infection. Moreover, CD4 + T cells produce copious amounts of IL-10, andmay be an important cellular source of IL-10 duringWNV infection in vivo. In conclusion, IL-10 signaling plays a negative role in immunity against WNV infection, and blockade of IL-10 signaling by genetic or pharmacologic means helps to control viral infection, suggesting a novel anti-WNV therapeutic strategy. © 2009 Bai et al.
CITATION STYLE
Bai, F., Town, T., Qian, F., Wang, P., Kamanaka, M., Connolly, T. M., … Fikrig, E. (2009). IL-10 signaling blockade controls murine West Nile virus infection. PLoS Pathogens, 5(10). https://doi.org/10.1371/journal.ppat.1000610
Mendeley helps you to discover research relevant for your work.